Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
Generic drugs play a crucial role in providing affordable medication options to patients worldwide. As we delve into the intricacies […]
Contribution of NIH funding to new drug approvals 2010–2016
This article was originally published by Ekaterina Galkina Cleary, Jennifer M. Beierlein, Navleen Surjit Khanuja, Laura M. McNamee and Fred D.
Contribution of NIH funding to new drug approvals 2010–2016 Read Post »
Understanding the Barriers to US Biosimilars: Navigating Challenges for Market Success
Biosimilars have emerged as a promising solution to reduce drug costs and increase patient access to life-saving treatments. However, the
Understanding the Barriers to US Biosimilars: Navigating Challenges for Market Success Read Post »
Formulary Decisions: Exploring the Ethics of Drug Approval
Formulary decisions play a crucial role in determining which medications are available to patients and at what cost. These decisions,
Formulary Decisions: Exploring the Ethics of Drug Approval Read Post »
Insights
Make Better Decisions With DrugPatentWatch
MAKE BETTER DECISIONS Join the 500+ leading biopharmaceutical companies we have served and make better decisions with DrugPatentWatch’s deep knowledge
Top 5 Challenges Faced By Biosimilars: Navigating the Complex Landscape
Biosimilars have emerged as a promising solution to reduce healthcare costs and improve patient access to life-saving biologics. However, the
Top 5 Challenges Faced By Biosimilars: Navigating the Complex Landscape Read Post »
Top 6 issues facing the biotechnology industry
The biotechnology industry is at the forefront of scientific innovation, promising groundbreaking solutions to some of the world’s most pressing
Tracking 20 Years of Compound-to-Target Output from Literature and Patents
This article was originally published by Christopher Southan, Peter Varkonyi, Kiran Boppana, Sarma A.R.P. Jagarlapudi, and Sorel Muresan at PLoS ONE
Tracking 20 Years of Compound-to-Target Output from Literature and Patents Read Post »
Can Artificial Intelligence Help Drug Development? Revolutionizing the Pharmaceutical Industry
In the ever-evolving landscape of pharmaceutical research, a new player has emerged that’s shaking up the industry: Artificial Intelligence (AI).
